NSHPT [OMIM #239200] is a clinically severe, ultra-rare disease associated with a high mortality usually caused by homozygous or compound heterozygous inactivating mutations in CaSR [2,41]. This evidence concerns the gene CASR and neonatal severe primary hyperparathyroidism.